ICAAC 52nd (2012)

Drupal spam blocked by CleanTalk.
Title Content type
Isavuconazole (ISA) Pharmacodynamic (PD) Target Determination for C. albicans (CA) in an in vivo Neutropenic Murine Model of Invasive Candidiasis (IC) (click for details)
In vitro activity of Isavuconazole against a worldwide collection of 237 Aspergillus terreus isolates and compared with 7 other Aspergillus active antifungal drugs tested with EUCAST and CLSI methodology (click for details)
In Vitro Activity of Isavuconazole Against Cryptococcus Isolates – A Pooled Analysis of 3 Studies (click for details)
Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of CYP3A4 Substrate Midazolam in Healthy Volunteers (click for details)
Risk Factors and Epidemiology of Candidemia by Candida guilliermondii (click for details)
ASP9726, A Unique 2nd Generation Echinocandin (1), Discovery of A Novel In Vitro Marker Correlated with in vivo Anti-Aspergillus Efficacy (click for details)
National Surveillance of Fungemia in Denmark 2010-11 (click for details)
Keyhole Limpet Hemocyanin (KLH) N-Glycans Share Similar Structural Features With Saccharides of Schistosoma, Trypanosoma, Leishmania, Cryptococcus, Aspergillis, Candida, E. coli, Salmonella, Clostridium and Hepatitis C virus (HCV) (click for details)
In Vitro Activity of E1210 and In Vivo Activity of E1211: A Water-Soluble Prodrug of E1210 in Combination with Other Antifungals (click for details)
ASP9726, A Unique 2nd Generation Echinocandin (5) -In Vitro and in vivo Activity of Combination Therapy with Voriconazole against Aspergillus fumigatus.- (click for details)


Subscribe to ICAAC 52nd (2012)